Key Metrics 
Check Before You Invest 
10 Yrs X-Ray 
Valuation 
Analyst Note 
Qtr. Results 
Financials 
News 
About
Jubilant Ingrevia Ltd (JUBLINGREA)
Share Analysis – Quality, Valuation Zone, Price Trend & DeciZen Rating BSE: 543271 NSE: JUBLINGREA Chemicals | Small Cap | Jubilant Ingrevia Share Price
₹624.95 -11.50 (-1.81%)
As on 18-Sep'26 16:59
Jubilant Ingrevia Ltd (JUBLINGREA)
Share Analysis – Quality, Valuation Zone, Price Trend & DeciZen Rating BSE: 543271 NSE: JUBLINGREA Chemicals | Small Cap | Jubilant Ingrevia Share Price
₹624.95 -11.50 (-1.81%)
As on 18-Sep'26 16:59
Key Metrics
Valuation Multiples
Market Cap
₹9,954 Cr.
Current Price
₹625
52-Week Low / High
₹535 / 795
TTM EPS
₹19.4
TTM Sales
₹4,604 Cr.
Book Value per Share
₹201.4
P/E Ratio
32.25
Lower than its 5-year historical median
Industry PE
48
Price to Book (P/B)
3.10
Lower than its 5-year historical median
Price to Sales (P/S)
2.16
In line with its 5-year historical median
EV/EBITDA
15.89
Lower than its 5-year historical median
Dividend Yield
0.8%
Profitability Efficiency
Return on Equity (ROE)
9.25%
In line with industry median
Return on Capital Employed (ROCE)
11.04%
Underperforms industry median
Return on Assets (ROA)
5.30%
Operating Profit Margin
13.4%
Net Profit Margin
6.33%
Gross Profit Margin
12.7%
Growth Momentum
1-yr vs 3-yr growth
1-yr vs 3-yr growth
Sales Growth (1 Year)
Improving versus 3-year growth rate
5.01%
Operating Profit Growth (1 Year)
Improving versus 3-year growth rate
9.24%
Net Profit Growth (1 Year)
Improving versus 3-year growth rate
10.64%
Asset Quality
Promoter Holding
45.22%
Pledged shares (%) of Promoter's holding (%)
9.30%
Reserves
₹3,192 Cr.
Equity
₹15.9 Cr.
Face Value
₹1
All Time Low / High
₹243.60 / 884.95
Check Before You Invest
Quality
Somewhat GoodValuation
FairCheck Valuation charts
Price Trend
Weak
Is Jubilant Ingrevia Ltd a good quality company?
Jubilant Ingrevia Ltd is a average quality company, based on a somewhat consistent multi-year financial track record.
This assessment is based on company’s performance on Revenue growth, ROCE, Equity and Assets, key margin ratios, cash conversion cycle, and debt to cash flow from operations and how it compares with its long term averages.
We have analysed the performance of the company on the following:
-
How has it performed on generating Profits?
By checking its Revenue growth, Gross, Operating and Net Margins compared to its last 5-year median.
-
How efficiently has it utilized Capital?
By checking its ROCE, ROA, ROE and its Cash Conversion Cycle.
-
How is it managing its Debt?
By checking its Debt to Equity and Cash Flow from Operations.
How does Jubilant Ingrevia Ltd performance compare with that of its Peers?
Revenue growth of Jubilant Ingrevia Ltd vs industry peers?
Jubilant Ingrevia Ltd revenue CAGR is 45.02%, compared to the industry median CAGR of 0%, indicating faster growth and gaining its market share.
Promoter shareholding and pledge status of Jubilant Ingrevia Ltd?
Promoters hold 45.22% of the Jubilant Ingrevia Ltd, with 9.30% of their stake pledged, indicating low pledge risk.
Stock return of Jubilant Ingrevia Ltd over the last decade?
Over the last 5 year(s), the stock has delivered a CAGR of -3.53% based on the current price.
10 Year X-Ray :
Analysis of Financial Track Record (Data adjusted to bonus, split, extra-ordinary income, rights issue and change in financial year end)
Data adjusted to bonus, split, extra-ordinary income, rights issue and change in financial year endData adjusted to bonus, split, extra-ordinary income, rights issue and change in financial year end.
What is a Financial Track Record? How to read this chart in order to understand the data present here?
Financial track record gives insight into the company's performance on key parameters over the past ten years. MoneyWorks4me’s proprietary colour codes make it easy for retail investors to gauge the company’s past performance.
Jubilant Ingrevia Ltd has performed well in some of the past ten years indicating its past ten year financial track record is somewhat good
Value Creation ⓘ
| Mar'17 | Mar'18 | Mar'19 | Mar'20 | Mar'21 | Mar'22 | Mar'23 | Mar'24 | Mar'25 | Mar'26 | TTM | |
|---|---|---|---|---|---|---|---|---|---|---|---|
| ROCE % ⓘ | 0% | 0% | 0% | 0% | 5.6% | 30.6% | 15.7% | 10.5% | 13% | 12.1% | - |
| Value Creation Index ⓘ | NA | NA | NA | NA | -0.6 | 1.3 | 0.2 | -0.2 | 0.0 | -0.1 | - |
Growth Parameters ⓘ |
|||||||||||
| Sales ⓘ | 0 | 0 | 0 | 0 | 669 | 4,860 | 4,560 | 3,987 | 3,941 | 4,138 | 4,375 |
| Sales YoY Gr. | - | NA | NA | NA | NA | 626.6% | -6.2% | -12.6% | -1.2% | 5% | - |
| Adj EPS ⓘ | 0 | 0 | 0 | -3.3 | 3.1 | 29.1 | 16.7 | 10.6 | 16.8 | 18.3 | 21 |
| YoY Gr. | - | NA | NA | NA | NA | 833.7% | -42.6% | -36.7% | 58.6% | 8.8% | - |
| BVPS (₹) ⓘ | 0 | 0 | 0 | -2.3 | 98.9 | 124.4 | 135.3 | 140.5 | 152.2 | 164.2 | 172.1 |
| Adj Net Profit ⓘ | 0 | 0 | 0 | -0.2 | 49.7 | 464 | 266 | 169 | 267 | 291 | 335 |
| Cash Flow from Ops. ⓘ | 0 | 0 | 0 | 0 | 104 | 587 | 446 | 394 | 441 | 462 | - |
| Debt/CF from Ops. ⓘ | 0 | 0 | 0 | 0 | 7.1 | 0.7 | 1.4 | 2.1 | 1.8 | 1.5 | - |
CAGR ⓘ
| 9 Years | 5 Years | 3 Years | 1 Years | |||||
|---|---|---|---|---|---|---|---|---|
| Sales ⓘ | NA | 44% | -3.2% | 5% | ||||
| Adj EPS ⓘ | NA | 42.4% | 3% | 8.8% | ||||
| BVPSⓘ | NA | 10.7% | 6.7% | 7.9% | ||||
| Share Price | - | -3.5% | 9.9% | -7.2% | ||||
Key Financial Parameters ⓘ
| Mar'17 | Mar'18 | Mar'19 | Mar'20 | Mar'21 | Mar'22 | Mar'23 | Mar'24 | Mar'25 | Mar'26 | TTM | |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Return on Equity % ⓘ | 0 | 0 | 0 | 143.1 | 6.3 | 26.1 | 12.9 | 7.7 | 11.4 | 11.5 | 12.5 |
| Op. Profit Mgn % ⓘ | 0 | 0 | 0 | 0 | 14.9 | 17.1 | 11.3 | 10.3 | 12.2 | 11.9 | 12.9 |
| Net Profit Mgn % ⓘ | 0 | 0 | 0 | 0 | 7.4 | 9.6 | 5.8 | 4.2 | 6.8 | 7 | 7.7 |
| Debt to Equity ⓘ | 0 | 0 | 0 | 0 | 0.5 | 0.2 | 0.3 | 0.4 | 0.3 | 0.3 | - |
| Working Cap Days ⓘ | 0 | 0 | 0 | 0 | 334 | 106 | 128 | 144 | 147 | 148 | 75 |
| Cash Conv. Cycle ⓘ | 0 | 0 | 0 | 0 | 15 | 22 | 38 | 43 | 45 | 40 | 12 |
Valuation of Jubilant Ingrevia - Consolidated
Analyst's Notes
No data found!
Management X-Ray
Shareholding Pattern
Promoter's Holding & Share Pledging
| Pledged * | 3.45 | 2.71 | 2.71 | 2.71 | 2.71 | 2.22 | 7.08 | 7.08 | 7.64 | 9.30 |
* Pledged shares as % of Promoter's holding (%)
Financials
| PARTICULARS | Mar'20 | Mar'21 | Mar'22 | Mar'23 | Mar'24 | Mar'25 | Mar'26 |
|---|---|---|---|---|---|---|---|
| Sales | 0 | 684 | 4,949 | 4,773 | 4,136 | 4,178 | 4,388 |
| Operating Expenses ⓘ + | 0 | 567 | 4,118 | 4,226 | 3,715 | 3,659 | 3,821 |
| Operating Profit ⓘ | -0 | 117 | 832 | 547 | 421 | 519 | 567 |
| Operating Profit Margin (%) | - | 17.1% | 16.8% | 11.5% | 10.2% | 12.4% | 12.9% |
| Other Income ⓘ + | 0 | 3 | 31 | 33 | 35 | 38 | 41 |
| Interest ⓘ | 0 | 7 | 31 | 22 | 53 | 56 | 49 |
| Depreciation ⓘ | 0 | 22 | 123 | 122 | 136 | 158 | 175 |
| Profit Before Tax ⓘ | -0 | 77 | 709 | 437 | 268 | 344 | 370 |
| Tax ⓘ | 0 | 23 | 232 | 129 | 85 | 92 | 92 |
| Profit After Tax | -0 | 54 | 477 | 307 | 183 | 251 | 278 |
| PAT Margin (%) | - | 8.0% | 9.6% | 6.4% | 4.4% | 6.0% | 6.3% |
| Adjusted EPS (₹) | -3.3 | 3.4 | 30.0 | 19.3 | 11.6 | 15.9 | 17.6 |
| Dividend Payout Ratio (%) | 0% | 10.30% | 16.70% | 25.90% | 43.20% | 31.50% | 28.40% |
| PARTICULARS | Mar'20 | Mar'21 | Mar'22 | Mar'23 | Mar'24 | Mar'25 | Mar'26 | ||||
|---|---|---|---|---|---|---|---|---|---|---|---|
Equity and Liabilities | |||||||||||
| Shareholders Fund + | -0 | 1,923 | 2,432 | 2,662 | 2,728 | 2,910 | 3,102 | ||||
| Debt + | 0 | 456 | 229 | 397 | 709 | 667 | 664 | ||||
| Minority Interest | 0 | 0 | 0 | 0 | 0 | 0 | 0 | ||||
| Trade Payables | 0 | 694 | 798 | 801 | 767 | 815 | 941 | ||||
| Others Liabilities ⓘ | 0 | 293 | 324 | 389 | 516 | 623 | 763 | ||||
| Total Liabilities ⓘ | 0 | 3,366 | 3,782 | 4,249 | 4,719 | 5,015 | 5,470 | ||||
Fixed Assets | |||||||||||
| Net Fixed Assets ⓘ + | 0 | 1,805 | 1,798 | 1,846 | 2,539 | 2,581 | 3,183 | ||||
| CWIP ⓘ | 0 | 65 | 174 | 525 | 331 | 525 | 154 | ||||
| Investments ⓘ | 0 | 50 | 6 | 8 | 15 | 37 | 33 | ||||
| Inventories | 0 | 609 | 911 | 1,035 | 941 | 943 | 880 | ||||
| Trade Receivables | 0 | 471 | 581 | 511 | 572 | 607 | 783 | ||||
| Cash Equivalents | 0 | 117 | 49 | 85 | 80 | 99 | 190 | ||||
| Others Assets ⓘ | 0 | 249 | 263 | 239 | 241 | 223 | 247 | ||||
| Total Assets ⓘ | 0 | 3,366 | 3,782 | 4,249 | 4,719 | 5,015 | 5,470 | ||||
| PARTICULARS | Mar'20 | Mar'21 | Mar'22 | Mar'23 | Mar'24 | Mar'25 | Mar'26 |
|---|---|---|---|---|---|---|---|
| Cash Flow From Operating Activity ⓘ + | 0 | 112 | 453 | 462 | 430 | 508 | 524 |
| Cash Flow From Investing Activity ⓘ + | 0 | -44 | -72 | -472 | -569 | -393 | -276 |
| Cash Flow From Financing Activity ⓘ + | 0 | -72 | -418 | 42 | 144 | -129 | -155 |
| Net Cash Flow ⓘ | 0 | -4 | -37 | 32 | 5 | -13 | 93 |
| PARTICULARS | Mar'20 | Mar'21 | Mar'22 | Mar'23 | Mar'24 | Mar'25 | Mar'26 | |||
|---|---|---|---|---|---|---|---|---|---|---|
| Ratios | ||||||||||
| ROE (%) | N/A | 5.65 | 21.89 | 12.07 | 6.79 | 8.91 | 9.25 | |||
| ROCE (%) | N/A | 6.86 | 28.84 | 16.01 | 9.8 | 11.16 | 11.04 | |||
| Asset Turnover Ratio | 0 | 0.41 | 1.39 | 1.19 | 0.92 | 0.86 | 0.84 | |||
| PAT to CFO Conversion(x) | N/A | 2.07 | 0.95 | 1.5 | 2.35 | 2.02 | 1.88 | |||
| Working Capital Days | ||||||||||
| Receivable Days | 0 | 250.60 | 38.80 | 41.70 | 47.70 | 51.40 | 57.70 | |||
| Inventory Days | 0 | 324 | 56 | 74.30 | 87 | 82.10 | 75.70 | |||
| Payable Days | 0 | 342.50 | 95.90 | 113 | 133.50 | 137 | 139.60 | |||
Top 5 Mutual Funds Holding
Last Visited Stocks
Announcements
Jubilant Ingrevia Ltd FAQs
The current trading price of Jubilant Ingrevia on 18-Sep-2026 16:59 is ₹625.0.
Market capitalization or market cap is determined by multiplying the current market price of a company's shares with the total number of shares outstanding. As of 17-Sep-2026 the market cap of Jubilant Ingrevia stood at ₹9,954.3 Cr
The latest P/E ratio of Jubilant Ingrevia as of 17-Sep-2026 is 29.70.
The latest P/B ratio of Jubilant Ingrevia as of 17-Sep-2026 is 3.63.
The 52-week high of Jubilant Ingrevia is ₹795.0 and the 52-week low is ₹535.3.
The TTM revenue is Trailing Twelve Months sales. The TTM revenue/sales of Jubilant Ingrevia is ₹4,375 ( Cr.) .
Past 10 year's financial track record analysis by Moneyworks4me indicates that Jubilant Ingrevia Ltd is a average quality company.
The key valuation ratios of Jubilant Ingrevia Ltd's currently when compared to its past seem to suggest it is in the Fair zone.
The Price Trend analysis by MoneyWorks4Me indicates it is Weak which suggest that the price of Jubilant Ingrevia Ltd is likely to Fall in the short term. However, please check the rating on Quality and Valuation before investing.
About Jubilant Ingrevia Ltd
Jubilant Ingrevia is a global integrated Life Science products and Innovative Solutions provider serving, Pharmaceutical, Nutrition, Agrochemical, Consumer and Industrial customers with its customised products and solutions that are innovative, cost-effective and conforming to excellent quality standards. Jubilant Ingrevia is the demerged pharma and life sciences business of Jubilant Lifesciences and listed on the exchanges in FY21.
Business area of the company
The company offers a broad portfolio of high-quality ingredients that find application in a wide range of industries. The company’s portfolio also extends to custom research and manufacturing for pharmaceutical and agrochemical customers on an exclusive basis.
Product and services
Speciality Chemicals
- Speciality Ingredients
- Fine Chemicals
- Crop Protection Chemicals
- CDMO
Nutrition & Health Solutions
- Nutrition & Health Ingredients
- Animal Nutrition & Health Solutions
- Human Nutrition & Health Solutions
Life Science Chemicals
- Life Science Ingredients
- Speciality Ethanol
You have 41 views remaining as a Guest User. To get DeciZen Rating of 3,500+ Stocks based on their Quality, Valuation and Price Trend Login Now
